FTC turning up the heat on homeopathic drugs

The Federal Trade Commission is preparing to clamp down on the advertising claims made by manufacturers of homeopathic drugs, an action that could cause a major shakeup in a multibillion-dollar industry....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch